Table 2. Univariate and multivariate Cox regression models for progression to psychosis (N=225).
Variables |
Model 1 |
Model 2 |
Model 3 |
|||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Univariate models | ||||||
rs4281084 (NRG1) | 1.55 (1.05–2.27) | 0.027 | ||||
rs12155594 (NRG1) | 2.29 (1.39–3.78) | 0.001 | ||||
Number of risk allelesa | 1.56 (1.20–2.04) | 0.001 | ||||
Multivariate models | ||||||
rs4281084 | 1.48 (0.97–2.25) | 0.071 | ||||
rs12155594 | 2.06 (1.21–3.49) | 0.008 | ||||
Number of risk allelesa | 1.47 (1.11–1.95) | 0.007 | ||||
Age | 0.97 (0.89–1.05) | 0.428 | 0.97 (0.89–1.05) | 0.410 | 0.97 (0.88–1.05) | 0.415 |
Sex | 1.00 (0.57–1.76) | 0.999 | 1.04 (0.59–1.82) | 0.907 | 1.00 (0.57–1.76) | 0.999 |
Duration of symptomsb | 1.00 (1.00–1.01) | 0.105 | 1.00 (1.00–1.01) | 0.076 | 1.00 (1.00–1.01) | 0.112 |
GAF score | 0.95 (0.92–0.98) | 0.002 | 0.95 (0.92–0.98) | 0.003 | 0.95 (0.92–0.98) | 0.002 |
BPRS total score | 0.95 (0.90–0.99) | 0.042 | 0.95 (0.91–1.01) | 0.078 | 0.95 (0.90–0.99) | 0.048 |
BPRS psychotic subscale | 1.07 (0.93–1.24) | 0.340 | 1.08 (0.92–1.24) | 0.340 | 1.08 (0.93–1.25) | 0.319 |
SANS attention subscale | 1.10 (0.95–1.28) | 0.195 | 1.09 (0.94–1.27) | 0.239 | 1.10 (0.94–1.27) | 0.237 |
Cannabis use (yes) | 0.34 (0.10–1.31) | 0.078 | 0.31 (0.09–1.03) | 0.060 | 0.31 (0.09–1.07) | 0.064 |
Abbreviations: BPRS, Brief Psychiatric Rating Scale; CI, confidence interval; GAF, Global Assessment of Functioning; HR, hazard ratio; SANS, Scale for the Assessment of Negative Symptoms.
rs4281084 A-alleles+rs1255594 T-alleles.
Time between onset of symptoms and first contact with PACE Clinic.